Impact of Neuropsychological Disorders in Multiple Sclerosis
Launched by LILLE CATHOLIC UNIVERSITY · Apr 7, 2021
Trial Information
Current as of October 17, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how neuropsychological disorders affect people with Multiple Sclerosis (MS). Specifically, it focuses on MS patients who have these disorders compared to those who do not. The goal is to understand the impact of these conditions on cognitive (thinking) and emotional health, as well as physical movement.
If you’re between the ages of 65 and 88, speak French, and have a specific type of MS called relapsing-remitting MS (with a mild level of disability), you may be eligible to participate. As a participant, you would undergo a routine assessment that includes tests for thinking skills and emotions, a physical examination, and a detailed analysis of your movements. It’s important to note that you should not have taken certain medications recently or have any serious health issues that would affect your participation. This study is currently recruiting participants, and your involvement could help improve understanding of how MS affects mental and physical health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Understanding and able to speak French
- • Carriers of MS with relapsing remitting form (RRMS-RR) with an EDSS \<4
- • No significant motor, cerebellar or somesthesia disorders of the upper limbs or visual disturbances (side to a visual EDSS \<2)
- • Absence of corticosteroid intake in the last four weeks
- • Benefiting from health insurance coverage
- • Not showing any flare-ups or worsening of the disease in the last 6 weeks
- • No botulinum toxin injection for more than 4 months
- Exclusion Criteria:
- • People with previous neurological pathologies, head trauma with loss of consciousness, psychiatric pathologies, serious general ailments, perceptual or dysarthric disorders preventing verbal communication or reading,
- • Treatment with psychotropic drugs (except benzodiazepines and hypnotics).
- • Refusal to participate after clear and fair information about the study.
- • Adults under tutorship, curatorship or safeguard of justice
- • With orthopedic treatment influencing walking
- • Pregnant woman
About Lille Catholic University
Lille Catholic University, a prominent academic institution in France, is dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates expertise from various fields to foster the development of cutting-edge medical solutions. Its commitment to ethical standards and patient-centered approaches ensures that clinical trials conducted under its auspices are rigorous, scientifically sound, and aligned with the highest standards of care. By leveraging its extensive network of researchers, healthcare professionals, and resources, Lille Catholic University plays a vital role in contributing to the enhancement of medical knowledge and the improvement of patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lille, France
Lomme, France
Lomme, France
Patients applied
Trial Officials
Caroline Massot, MD
Study Director
GHICL
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials